$241.34
0.44% yesterday
NYSE, Jun 13, 10:00 pm CET
ISIN
IE00BFY8C754
Symbol
STE

Steris Stock price

$241.34
+10.19 4.41% 1M
+27.12 12.66% 6M
+35.78 17.41% YTD
+20.29 9.18% 1Y
+87.49 56.87% 5Y
+178.22 282.35% 10Y
+217.95 931.89% 20Y
NYSE, Closing price Fri, Jun 13 2025
-1.07 0.44%
ISIN
IE00BFY8C754
Symbol
STE
Sector

Key metrics

Market capitalization $23.85b
Enterprise Value $25.72b
P/E (TTM) P/E ratio 38.97
EV/FCF (TTM) EV/FCF 33.06
EV/Sales (TTM) EV/Sales 4.71
P/S ratio (TTM) P/S ratio 4.37
P/B ratio (TTM) P/B ratio 3.61
Dividend yield 0.92%
Last dividend (FY25) $2.23
Revenue growth (TTM) Revenue growth 6.24%
Revenue (TTM) Revenue $5.46b
EBIT (operating result TTM) EBIT $972.00m
Free Cash Flow (TTM) Free Cash Flow $778.00m
Cash position $171.70m
EPS (TTM) EPS $6.22
P/E forward 30.31
P/S forward 4.10
EV/Sales forward 4.42
Short interest 1.18%
Show more

Is Steris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Steris Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Steris forecast:

6x Buy
60%
4x Hold
40%

Analyst Opinions

10 Analysts have issued a Steris forecast:

Buy
60%
Hold
40%

Financial data from Steris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
5,460 5,460
6% 6%
100%
- Direct Costs 3,057 3,057
5% 5%
56%
2,403 2,403
8% 8%
44%
- Selling and Administrative Expenses 1,323 1,323
8% 8%
24%
- Research and Development Expense 108 108
4% 4%
2%
1,448 1,448
0% 0%
27%
- Depreciation and Amortization 476 476
16% 16%
9%
EBIT (Operating Income) EBIT 972 972
9% 9%
18%
Net Profit 615 615
62% 62%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Steris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Steris Stock News

Neutral
GlobeNewsWire
25 days ago
Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report by Product (Gynecological Chairs, Gynecological Tables), Application (Urology Surgery, Pelvic Surgery), End-use, with Growth Forecasts, 2025-2030" report has been added to ResearchAndMarkets.com's offering. The U.S. Gynecological Chairs and Tables Market was valued at U...
Positive
Seeking Alpha
29 days ago
Steris plc remains a Strong Buy with a fair value of $281, supported by robust organic growth and margin expansion. The Trump administration's push to reshore pharma manufacturing could be a major tailwind for Steris's AST business. Steris's balanced growth in pricing and volume, along with cost initiatives, positions it for continued operating margin improvement.
Neutral
Seeking Alpha
29 days ago
STERIS plc (NYSE:STE ) Q4 2025 Results Conference Call May 15, 2025 9:00 AM ET Company Participants Julie Winter - Investor Relations Mike Tokich - Senior Vice President and Chief Financial Officer Dan Carestio - President and Chief Executive Officer Conference Call Participants Dave Turkaly - Citizens Mike Matson - Needham & Company Patrick Wood - Morgan Stanley Mac Etoch - Stephens, Inc Micha...
More Steris News

Company Profile

STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Daniel Carestio
Employees 18,000
Founded 2016
Website www.steris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today